Abn Amro Investment Solutions Hutchmed (China) LTD Transaction History
Abn Amro Investment Solutions
- $4.88 Trillion
- Q3 2025
A detailed history of Abn Amro Investment Solutions transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Abn Amro Investment Solutions holds 62,277 shares of HCM stock, worth $939,137. This represents 0.02% of its overall portfolio holdings.
Number of Shares
62,277
Previous 63,915
2.56%
Holding current value
$939,137
Previous $962 Million
1.97%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding HCM
# of Institutions
59Shares Held
6.01MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.47MShares$37.2 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M909KShares$13.7 Million0.02% of portfolio
-
Jane Street Group, LLC New York, NY340KShares$5.13 Million0.0% of portfolio
-
State Street Corp Boston, MA318KShares$4.79 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.76 Million0.11% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.61B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...